Workflow
Forbes
icon
Search documents
30% Upside For Palantir Stock?
Forbes· 2025-10-30 14:00
The stock of Palantir Technologies (PLTR) has surged 13% over the past week and is currently priced at $198.81. A laptop keyboard and Palantir logo displayed on a phone screen are seen in this multiple exposure illustration photo taken in Krakow, Poland on May 6, 2025. (Photo by Jakub Porzycki/NurPhoto via Getty Images)NurPhoto via Getty ImagesSo should you be accumulating more PLTR stock? A target price of $259 may be feasible. The company has posted Very Strong operational results and financial health in ...
Bending Spoons Cofounders Become Billionaire After Italian Startup Raises At $11 Billion Valuation
Forbes· 2025-10-30 13:57
Bending Spoon's Luca Ferrari and his three cofounders started to acquire apps back in 2014. Fresh from signing a deal to buy AOL, a new funding round values their startup at over $11 billion.Bending SpoonsLuca Ferrari bought his first app back in 2014 for just $10,000 with the hope that he and his three cofounders in Milan-based startup Bending Spoons could turn it around. A decade later, Ferrari has become one of tech’s biggest dealmakers, and a new billionaire, after a new funding round valued his startup ...
Stride Crashes 50%, Should You Buy More?
Forbes· 2025-10-30 13:30
Core Insights - Stride (LRN) stock plummeted by 54.4% in a single day despite reporting better-than-expected Q1 earnings, as investors reacted negatively to the company's weak outlook and operational challenges [2] - The adjusted EPS was $1.52, with a revenue increase of 12.7% to $620.9 million, surpassing estimates; however, management's guidance for future sales fell short of Wall Street expectations, raising concerns about growth momentum [2] - The company highlighted issues with technology rollouts and increased student withdrawal rates, indicating execution challenges that could hinder future growth [2] Financial Performance - Stride is currently valued at $3.0 billion with $2.5 billion in revenue, trading at $70.05 [7] - The company has experienced a revenue growth of 17.3% over the past 12 months, with an operating margin of 17.8% [7] - Stride's stock is trading at a P/E multiple of 9.6 and a P/EBIT multiple of 7.2 [7] Historical Stock Performance - LRN stock has shown a median return of -2.4% within a year following sharp declines since 2010 [7] - The stock dropped 32.8% from a peak of $46.56 on October 21, 2022, to $31.28 on December 30, 2022, while the S&P 500 experienced a peak-to-trough decline of 25.4% [8] - Despite these declines, LRN stock fully recovered to its pre-Crisis peak by October 25, 2023, and reached a peak of $169.81 on August 27, 2025, before currently trading at $70.05 [8] Risk and Recovery Analysis - The stock has historically faced challenges in recovery after significant declines, with a notable drop of 59.2% from a high of $51.60 on August 5, 2020, to $21.05 on November 10, 2020, compared to a 33.9% decline for the S&P 500 [10] - LRN stock has consistently recovered to its pre-Crisis peaks after major downturns, indicating resilience in its long-term performance [10]
Adobe Stock Dropped Yesterday, Should You Buy It Now?
Forbes· 2025-10-30 13:05
Core Insights - Adobe's stock (NASDAQ: ADBE) saw a significant decline of 6.1% on October 29, 2025, despite multiple AI-focused product announcements at its annual MAX conference, indicating investor concerns about the long-term competitive impact of AI on the business [2][3] - The stock has experienced a substantial decline of 60.0% from its peak of $688.37 on November 19, 2021, to $275.20 on September 30, 2022, underperforming the S&P 500, which had a peak-to-trough drop of 25.4% during the same period [7] - Adobe's stock has not yet returned to its pre-crisis peak, with the highest value since then being $634.76 on February 4, 2024, and it currently trades at $337.86 [7] Stock Performance Analysis - During the 2020 COVID-19 pandemic, ADBE stock declined by 25.6% from a peak of $383.28 on February 19, 2020, to $285.00 on March 12, 2020, while the S&P 500 experienced a peak-to-trough decline of 33.9% [9] - ADBE stock fully recovered to its pre-crisis peak by May 20, 2020, demonstrating resilience during that downturn [9] - In the 2018 correction, ADBE stock dropped 25.5% from a peak of $275.49 on October 1, 2018, to $205.16 on December 24, 2018, compared to a 19.8% decline for the S&P 500, and it also fully recovered by April 23, 2019 [9] Investment Strategy Considerations - Investing in a single stock like ADBE can be risky, and a diversified strategy, such as the Trefis High Quality Portfolio, is recommended to mitigate stock-specific risk while providing upside potential [4] - The Trefis High Quality Portfolio has consistently outperformed its benchmark, which includes the S&P 500, S&P mid-cap, and Russell 2000 indices, indicating a strategy that provides superior returns with reduced risk [8]
20% Upside For Eli Lilly Stock?
Forbes· 2025-10-30 13:05
Core Insights - Eli Lilly's stock has increased by 7% over the past month, driven by a partnership with Walmart to sell its weight-loss drug, Zepbound, at a discounted price [2] - The stock is currently trading within a support range of $772.85 to $854.21, which has historically attracted significant buying interest [3] - Following previous rebounds from this support range, Eli Lilly's stock has achieved an average peak return of 20.2% [3] Financial Performance - Eli Lilly reported a revenue growth of 36.8% for the last twelve months (LTM) and an average growth of 23.4% over the past three years [5] - The company has a free cash flow margin of approximately -0.09% and an operating margin of 43.0% LTM [5] - The lowest annual revenue growth in the last three years was 1.5% [5] - Eli Lilly's stock trades at a price-to-earnings (PE) ratio of 52.9 [5] Market Position - Compared to the S&P 500, Eli Lilly offers a higher valuation, increased revenue growth, and superior operating margins [5] - The stock has historically faced significant declines during market downturns, including a 51% drop during the Global Financial Crisis and a 43% drop during the Dot-Com bubble [6]
Is AVGO Stock Beating Competition?
Forbes· 2025-10-30 13:05
Core Insights - Broadcom stock (NASDAQ: AVGO) has experienced a 13% increase in a week, driven by momentum in the AI sector [2] - The stock's performance warrants a re-evaluation within a robust investment strategy [2] Group 1: Company Overview - Broadcom specializes in semiconductor devices and infrastructure software, including solutions for set-top box system-on-chips, cable, DSL, and passive optical networking [3] Group 2: Recent Developments - The company has secured a significant AI-driven partnership with OpenAI for custom chips and networking solutions, reinforcing its market position [6] - A new supercomputer project between Nvidia and Oracle has increased demand for Broadcom's connectivity chips, essential for linking Nvidia's GPUs [6] Group 3: Stock Performance and Comparison - Broadcom's stock rose by 17% in a month, prompting a comparison against peers to assess performance, valuation, and financial metrics [5] - The High Quality Portfolio has outperformed its benchmark, achieving returns exceeding 105% since inception, indicating a strategy for less volatility compared to individual stocks like AVGO [4]
GOOGL Stock vs. META Stock
Forbes· 2025-10-30 12:30
Core Insights - Alphabet (Google) and Meta Platforms experienced contrasting stock reactions after their Q3 earnings reports, despite both being significant players in the AI sector [2]. Alphabet (Google) Summary - Google stock increased by 8% in after-hours trading, driven by a strong Q3 performance with revenue of $102.4 billion, exceeding Wall Street's expectations of $99.85 billion [3]. - The revenue growth was significantly supported by Google Cloud, which reported a 34% increase in revenue to $15.2 billion [3]. - Adjusted earnings per share (EPS) were $2.87, surpassing the projected $2.27 and the previous year's EPS of $2.12 [3]. Meta Platforms Summary - Meta Platforms' stock fell by 8% in after-hours trading following disappointing results, reporting Q3 revenue of $51.24 billion and EPS of $1.05 [4]. - Although revenue slightly exceeded expectations of $49.6 billion, the EPS missed projections of $6.72, primarily due to a one-time tax-related charge [4]. - The decline in stock price may also reflect profit-taking by investors after pre-earnings interest [4]. Comparative Analysis - Despite Google's strong quarterly performance, there is a preference for Meta based on its stronger underlying revenue growth, better operating margins, and relatively lower valuation compared to Google [5]. - Meta's latest quarterly revenue growth was 26%, compared to Google's 16% [6]. - Meta's Last 12 Months (LTM) revenue growth was 15.2%, ahead of Google's 13.6% [6]. - Meta demonstrated stronger profitability with an LTM margin of 42.6% and a 3-year average margin of 34.6% [6].
Buy or Sell Fiserv Stock After Its 44% Crash?
Forbes· 2025-10-30 11:25
Core Insights - Fiserv's stock experienced a significant decline of 44% on October 29, 2025, following disappointing third-quarter earnings and a lowered full-year forecast [2][3] Financial Performance - Adjusted earnings per share were reported at $2.04, missing the analyst consensus of $2.72, while revenue of $5.26 billion fell short of the $5.56 billion forecast [3] - The company revised its full-year earnings guidance down to a range of $8.50-$8.60 per share from a previous outlook of $10.15-$10.30 [3] - Organic revenue growth slowed to just 1% for the quarter, with particularly weak performance in the Merchant Solutions segment [4] - Fiserv's revenues grew 5.2% from $20 billion to $21 billion over the last 12 months, compared to a 5.4% increase for the S&P 500 [14] Operational Challenges - Management cited a slowdown in cyclical growth in Argentina and the impact of interest rates as contributing factors to the weak performance [4] - There was a sudden senior leadership overhaul and ongoing legal concerns regarding alleged inflated growth tied to the Clover platform, adding to investor uncertainty [4] Valuation Metrics - Fiserv's price-to-sales (P/S) ratio stands at 1.8, compared to 3.2 for the S&P 500, indicating a lower valuation relative to the broader market [7] - The company's price-to-earnings (P/E) ratio is 10.9 versus the benchmark's 23.6, suggesting it may be undervalued [7] Profitability and Financial Stability - Fiserv's operating income over the last four quarters was $6.2 billion, with an operating margin of 29%, significantly higher than the S&P 500's 18.7% [14] - The company's balance sheet appears weak, with a debt figure of $30 billion and a high debt-to-equity ratio of 76.5% compared to 21.2% for the S&P 500 [14] Market Resilience - Fiserv stock has shown more resilience compared to the S&P 500 during recent downturns, recovering fully from previous market crises [15]
Cigna Profits Hit Nearly $2 Billion Despite Rising Costs
Forbes· 2025-10-30 10:15
Core Insights - Cigna Group reported a third quarter net income of nearly $2 billion, reflecting strong performance despite rising costs in health plans [2][6] - The company's medical cost ratio increased to 84.8% in Q3 2025 from 82.8% in Q3 2024, attributed to individual and family plans and higher stop loss medical costs [4][5] - Total revenues for Cigna rose by 10% to $69.7 billion, driven primarily by Evernorth Health Services and growth in existing client relationships [7] Financial Performance - Cigna's net income for Q3 2025 was $1.9 billion, or $6.98 per share, compared to $0.7 billion, or $2.63 per share, in Q3 2024, which included a one-time non-cash after-tax investment loss of $1.0 billion [6] - The increase in net income indicates effective management and execution of growth strategies in a challenging environment [7] Industry Context - Cigna's medical cost ratio, while rising, remains lower than many competitors in the health insurance industry, which are experiencing ratios of 90% or more [5] - The company has distinct medical cost challenges compared to rivals, particularly those focused on government-subsidized health insurance programs like Medicaid and Medicare Advantage [5]
Oil Forecast Contrasts With Resilient Energy Stocks
Forbes· 2025-10-30 09:30
Core Viewpoint - The crude oil market is experiencing a negative trend, with recent price movements indicating potential challenges ahead for both crude oil prices and energy stocks [2][5][12]. Price Movements - Crude oil prices rallied to $78.40 in June but closed the week at $65.52, indicating a failure to establish a positive trend [2]. - After hitting a low of $62.17 in June, crude oil increased by 6.5% to close July at $69.36, but the overall trend remains negative [3]. - In August, crude oil prices fell by 7.7%, while the Energy Select Sector SPDR Fund (XLE) gained 3.7% [5]. Technical Analysis - The monthly DTS indicator generated a sell signal in November 2024, confirming a new downtrend after a break of support in April 2025 [3]. - The 20-month EMA has been declining since November 2023, reinforcing the negative trend, currently positioned at $68.84 [6]. - The 4th Quarter pivot is at $64.80, with the OBVplus indicating a continued downtrend favoring lower prices [7]. Resistance and Support Levels - Strong resistance is noted in the $66.40 area, with a weekly starc+ band at $68.98 [8]. - Support levels are identified at $55.12 and a post-Covid support line around $33 [8]. Volume and Money Flow - The on-balance-volume (OBV) is below its WMA, indicating a negative long-term pattern of lower highs and lower lows [9]. - The Herrick Payoff Index (HPI) has dropped below the zero line, signaling negative money flow [9]. Seasonal Trends - The seasonal trend for crude oil typically peaks in July and bottoms out around December 13th, aligning with the current monthly technical trend [10]. Relative Performance - The Energy Select Sector (XLE) is down 2.2% for the month but up 3.6% year-to-date, lagging behind the S&P 500, which is up over 17.3% YTD [10][11]. - The relative performance peaked in late 2022 and has diverged from prices since 2023, remaining below its WMA [11]. Future Outlook - The monthly and weekly analyses are negative for crude oil, while the daily analysis shows slight positivity, suggesting a potential rebound that may ultimately fail [12]. - The preliminary yearly pivot for crude oil in 2026 is set at $85.55, which will be monitored as the year concludes [12].